ATP Holdings ehf. reported recent share transactions involving Alvotech, including an acquisition and a corrected sale announcement.
Quiver AI Summary
ATP Holdings ehf. has submitted two filings to the Luxembourg CSSF regarding share transactions involving managers and their closely associated individuals. On December 17, 2025, the company acquired 4,812,257 shares in Alvotech, and on December 19, 2025, it sold 2,110,640 shares, with both transactions priced at SEK 44.06 per share. It was noted that a previous announcement on January 6, 2025, incorrectly described the December 19 transaction as an acquisition rather than a sale.
Potential Positives
- ATP Holdings ehf. is actively managing its investment in Alvotech, indicating ongoing strategic engagement with a key asset.
- The acquisition of 4,812,257 shares demonstrates confidence in Alvotech’s future potential, which could positively influence investor perception.
- The transparency of reporting transactions to the Luxembourg CSSF reflects compliance with regulatory standards, enhancing the company's reputation for accountability.
Potential Negatives
- The press release indicates a correction of information regarding the December 19 transaction, which may raise concerns about the accuracy and reliability of the company's reporting practices.
- The timing of the acquisitions and sales of shares by managers and closely associated persons could raise questions about the company's internal governance and transparency.
FAQ
What transactions did ATP Holdings ehf. announce?
ATP Holdings ehf. announced the acquisition of 4,812,257 shares and the sale of 2,110,640 shares in Alvotech.
What were the transaction dates for ATP Holdings ehf.?
The acquisition took place on December 17, 2025, and the sale occurred on December 19, 2025.
What was the share price for the transactions?
The transaction price for both the acquisition and sale was SEK 44.06 per share.
Was there an error in the initial announcement?
Yes, the initial announcement incorrectly referred to the December 19, 2025, transaction as an acquisition.
Where were the filings regarding these transactions made?
The filings were made with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ALVO Hedge Fund Activity
We have seen 38 institutional investors add shares of $ALVO stock to their portfolio, and 22 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HEIGHTS CAPITAL MANAGEMENT, INC removed 1,090,664 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,932,538
- GILDER GAGNON HOWE & CO LLC removed 195,345 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,599,875
- MORGAN STANLEY removed 182,224 shares (-51.0%) from their portfolio in Q3 2025, for an estimated $1,492,414
- ROYCE & ASSOCIATES LP removed 148,728 shares (-54.5%) from their portfolio in Q3 2025, for an estimated $1,218,082
- MARSHALL WACE, LLP added 136,859 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,120,875
- LEGAL & GENERAL GROUP PLC removed 130,874 shares (-19.9%) from their portfolio in Q3 2025, for an estimated $1,071,858
- VANGUARD GROUP INC added 114,255 shares (+2.7%) to their portfolio in Q3 2025, for an estimated $935,748
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ALVO Analyst Ratings
Wall Street analysts have issued reports on $ALVO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/18/2025
- Morgan Stanley issued a "Overweight" rating on 10/14/2025
To track analyst ratings and price targets for $ALVO, check out Quiver Quantitative's $ALVO forecast page.
$ALVO Price Targets
Multiple analysts have issued price targets for $ALVO recently. We have seen 5 analysts offer price targets for $ALVO in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $5.0 on 12/09/2025
- Ashwani Verma from UBS set a target price of $10.0 on 11/18/2025
- Niall Alexander from Deutsche Bank set a target price of $8.0 on 11/04/2025
- Thibault Boutherin from Morgan Stanley set a target price of $14.0 on 10/14/2025
Full Release
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons. ATP Holdings ehf. announced two transactions, an acquisition of 4,812,257 shares in Alvotech on December 17, 2025, and a sale of 2,110,640 shares in Alvotech on December 19, 2025. The transaction price in both cases was SEK 44.06 per share.
(In the original version of the announcement issued on January 6, 2025, the December 19, 2025, transaction was incorrectly referred to as an acquisition of shares.)
Attachments
